Xbrane Biopharma and Episurf invites to a company presentation in Stockholm May 29

Press release

Xbrane Biopharma and Episurf Medical invites to a company presentation held at Episurf Medical's office at Karlavägen 60 in Stockholm on May 29, 18.00-20.30 CEST.

Xbrane Biopharma will be represented by CEO Martin Åmark and Episurf by Pål Ryfors. The presentation will be broadcasted via Finwire.

A light meal will be served during the evening.

Registration should be sent to info@xbrane.com or info@episurf.com.

About Xbrane
Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars and long-acting injectables. Xbrane has world leading expertise in developing generics for long-acting injectable drugs and proprietary high-yield protein expression technology for the development of biosimilars. Xbrane's headquarter is located in Stockholm and the company's in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd, 2016 under the name XBRANE and Avanza Bank AB is Xbrane's certified adviser. For more information see www.xbrane.com.

For further information, please contact:
Martin Åmark
Chief Executive Officer
M: +46 (0) 763-093 777
E: martin.amark@xbrane.com

Susanna Helgesen
CFO/IR, Xbrane Biopharma AB
M: +46 (0) 708-278 636
E: susanna.helgesen@xbrane.com